Welcome to our dedicated page for Sharps Tech SEC filings (Ticker: STSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sharps Technology Inc. (NASDAQ: STSS) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into how Sharps Technology describes its medical device activities, smart-safety syringe and pharmaceutical packaging products, medical device distribution operations, and its Solana-based digital asset treasury strategy.
Through periodic reports such as the Form 10-K annual report and Form 10-Q quarterly reports, investors can review information on business segments, risk factors related to medical devices and digital assets, capital structure, and the financial impact of activities like SOL acquisitions, staking revenue, and fair-value changes. Current reports on Form 8-K highlight material events, including the launch and terms of large private placements, the authorization of a $100 million stock repurchase program, entry into share repurchase agreements, settlement agreements involving asset transfers, and special stockholder meeting outcomes related to warrant share issuances.
Proxy materials such as the DEF 14A definitive proxy statement provide additional context on governance matters, including director elections and proposals to approve the issuance of shares upon the exercise of cryptocurrency-related pre-funded and stapled warrants and strategic advisor warrants. Together, these filings outline how Sharps Technology structures its capital markets activity to support both its medical device distribution business and its Solana-focused treasury model.
On Stock Titan, these SEC filings are updated in real time from EDGAR and are paired with AI-powered summaries that explain key points in plain language. Users can quickly understand the implications of lengthy 10-K and 10-Q reports, review 8-K disclosures about treasury strategy developments or repurchase programs, and track warrant-related approvals and other corporate actions. This page also surfaces information relevant to insider and major holder activity through ownership and transaction filings when available, helping investors analyze how Sharps Technology’s leadership and significant holders interact with the company’s equity over time.
Saba Capital Management and affiliates have filed an amended Schedule 13G reporting a significant passive stake in Sharps Technology, Inc. The filing shows that Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (together, the reporting persons) beneficially own 3,195,097 shares of Sharps Technology common stock and warrants, representing 10.46% of the class.
The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025, plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons. All 3,195,097 shares are reported with shared voting and shared dispositive power, and none with sole power. The funds and accounts advised by Saba Capital have the right to receive dividends and sale proceeds, and the reporting persons certify the securities are not held to change or influence control of Sharps Technology.
Saba Capital Management and affiliates have reported a significant stake in Sharps Technology, Inc. In this amended Schedule 13G, Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein disclose beneficial ownership of 1,741,214 shares and warrants of Sharps Technology common stock, representing 5.93% of the class as of the event date of 12/31/2025.
The ownership percentage is based on 28,995,402 shares outstanding as of December 15, 2025, plus 388,462 shares issuable upon exercise of certain warrants held by the reporting persons. All voting and dispositive power over these securities is reported as shared, with no sole voting or dispositive power. The filing states that the securities were not acquired and are not held for the purpose of changing or influencing control of Sharps Technology, characterizing this as a passive investment position held on behalf of funds and accounts advised by Saba Capital.
Saba Capital Management and related parties have disclosed a new passive stake in Sharps Technology, Inc. The group, including Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, reports beneficial ownership of 1,583,749 shares and warrants of Sharps Technology common stock, equal to 5.53% of the class.
The ownership percentage is based on 28,226,153 shares outstanding as of October 17, 2025, plus 388,462 shares issuable upon exercise of certain warrants held by the reporting persons. The securities are held for the benefit of funds and accounts advised by Saba Capital. The filers certify that the holdings were not acquired and are not held for the purpose of changing or influencing control of Sharps Technology.
Sharps Technology Inc. large shareholder Saba Capital Management, L.P. reported two sales of the company’s common stock. On January 13, 2026, Saba Capital sold 29,777 shares at a price of $2.19 per share. On January 14, 2026, it sold another 77,688 shares at $2.25 per share. After these indirect transactions, Saba Capital reported beneficial ownership of 1,626,858 shares following the first sale and 1,549,170 shares following the second sale.
Saba Capital Management, L.P. has filed an initial ownership report as a 10% owner of Sharps Technology Inc. (STSS) as of 01/09/2026. The filing shows indirect beneficial ownership of 1,656,635 shares of common stock.
Saba Capital also indirectly holds cash stapled warrants exercisable into 1,538,462 shares of common stock at an exercise price of $9.75, expiring on 11/04/2028, and pre-funded warrants for 388,462 shares of common stock at $6.50 per share, noted as expiring when exercised in full.
Sharps Technology (STSS) filed its Q3 2025 10‑Q, highlighting a major shift to a digital‑asset treasury anchored in Solana (SOL). As of September 30, total assets were $443.96M, including SOL at fair value of $404.20M and USDC of $14.70M. Cash was $10.52M. Management states current liquidity is sufficient for the next twelve months and no longer raises substantial doubt about going concern.
Operations reflected the pivot: product revenue was $83,622, and staking revenue was $2,205,423. The quarter included significant operating costs, including selling, general and administrative expenses of $110.72M and a $7.50M impairment of fixed assets tied to the exit from manufacturing, resulting in a net loss of $105.33M. A 10% change in SOL prices would have impacted income by about $40.4M for the period, underscoring market sensitivity.
Financing activity was robust, with $210.73M of net cash provided year‑to‑date. The company received $144.04M of digital assets and $86.10M of USDC from common stock issuances. Shares outstanding were 27,626,498 at quarter‑end and 28,226,153 as of November 14, 2025. Sharps now reports two segments: Medical Device Packaging Products and Digital Assets.
Sharps Technology, Inc. (Nasdaq: STSS)
The company is not selling shares and will not receive proceeds from Selling Stockholder sales. It could receive up to $614,837,807.75 in gross proceeds if all warrants are exercised. Shares outstanding were 28,226,153 as of October 17, 2025. The company highlights extensive risk factors tied to its SOL-focused digital asset treasury strategy, staking operations, market volatility, custody, DeFi usage, and evolving regulation.
Sharps Technology (STSS) reported results of its special meeting of stockholders. Of 26,600,848 shares eligible to vote as of September 16, 2025, 17,779,090 shares were present or represented by proxy, establishing a 66.9% quorum.
Stockholders elected Annemarie Tierney as director with 17,770,289 votes for and 8,801 withheld. Proposal 2 was approved with 17,750,927 votes for, 27,713 against, and 450 abstentions. Proposal 3 was approved with 17,743,259 votes for, 35,546 against, and 285 abstentions. Proposal 4 was approved with 16,802,916 votes for, 51,835 against, and 924,339 abstentions.
Sharps Technology, Inc. approved a 2025 share repurchase program authorizing the company to buy back up to $100,000,000 of its outstanding common stock. The program allows repurchases in the open market and through negotiated transactions, with the amount and timing of purchases depending on available capital, financial and operational performance, market conditions, securities law limits, and other factors, and does not obligate the company to repurchase any shares.
To facilitate these buybacks, Sharps Technology entered into an Open Market Share Repurchase Agreement with Cantor Fitzgerald & Co., which will act as a non-exclusive agent to repurchase shares under Rule 10b-18 of the Exchange Act. The agreement remains in effect until either party terminates it by written notice, and the company will pay the broker a commission of $0.02 per share repurchased.
Sharps Technology, Inc. disclosed that its Board of Directors has authorized a stock repurchase program. This program allows the company to buy back its common shares in the open market and through negotiated transactions, which can reduce the number of shares available in the market over time. The announcement was made via a press release dated October 2, 2025, which is included as an exhibit to the report.